Literature DB >> 10636078

Folding of oligoglutamines: a theoretical approach based upon thermodynamics and molecular mechanics.

E B Starikov1, H Lehrach, E E Wanker.   

Abstract

Folding of oligoglutamine chains of different lengths is of crucial interest for exploring the molecular mechanisms of Huntington's disease. A simple oligoglutamine model based upon the Flory-Huggins theory of polymer solutions demonstrates a random coil instability in chains containing more than 40 glutamine residues with respect to beta-sheet formation. This is in striking quantitative agreement with biochemical results on the chain length dependence of polyglutamine aggregation in vivo and in vitro, as well as with clinical data on the polyglutamine chain length dependence of the onset of Huntington's disease. Furthermore, a detailed molecular-mechanical investigation of a polypeptide chain carrying 40 glutamine residues was performed. Two possible folding modes of such an oligoglutamine chain were revealed: a) a beta-hairpin and b) a highly compact random coil entity stabilized by a wealth of H-bonds among the glutamine side chains. A possible role of these folding modes in polyglutamine aggregation, as well as in the onset of Huntington's disease, is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10636078     DOI: 10.1080/07391102.1999.10508374

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  13 in total

1.  Polyglutamine fibrillogenesis: the pathway unfolds.

Authors:  Christopher A Ross; Michelle A Poirier; Erich E Wanker; Mario Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

Review 2.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

3.  A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory.

Authors:  John M Finke; Margaret S Cheung; José N Onuchic
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

4.  Chaperone-like N-methyl peptide inhibitors of polyglutamine aggregation.

Authors:  Jennifer D Lanning; Andrew J Hawk; Johnmark Derryberry; Stephen C Meredith
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

Review 5.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

6.  Side-chain interactions determine amyloid formation by model polyglutamine peptides in molecular dynamics simulations.

Authors:  Alexander J Marchut; Carol K Hall
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

7.  Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent.

Authors:  Karunakar Kar; Murali Jayaraman; Bankanidhi Sahoo; Ravindra Kodali; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

8.  Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization.

Authors:  Andreas Vitalis; Xiaoling Wang; Rohit V Pappu
Journal:  J Mol Biol       Date:  2008-09-18       Impact factor: 5.469

9.  Mutational analysis of the structural organization of polyglutamine aggregates.

Authors:  Ashwani K Thakur; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

10.  Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories.

Authors:  Andreas Vitalis; Xiaoling Wang; Rohit V Pappu
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.